As a biopharmaceutical manufacturer you would like to carry out an analysis of n-glycans
What are n-glycans?
N-Glycans are complex carbohydrate structures (glycans) covalently attached to proteins via an asparagine residue (N-glycosylation). This type of post-translational modification plays a crucial role in protein stability, solubility, function and immunogenicity.
Classification of N-glycans
Why do an n-glycan analysis?
N-Glycans are particularly studied in biopharmaceuticals, notably for the characterization of monoclonal antibodies (mAbs) and therapeutic proteins, where their glycosylation profile directly impacts the efficacy and safety of treatments.
N-Glycans play a key role in many biological processes and directly impact the stability, efficacy and immunogenicity of biomolecules, particularly in the pharmaceutical and biotechnology sectors. A precise analysis of these glycosylated structures is essential for the development and quality control of biomedicines, as well as to meet current regulatory requirements.
FILAB supports biopharmaceutical manufacturers in the analysis of n-glycans
Why choose FILAB for n-glycans analysis?
FILAB, an analytical expertise laboratory, offers analysis services for your N-Glycans using cutting-edge techniques adapted to industrial constraints and regulatory requirements. Our analytical approach allows us to identify, quantify and characterize the glycosylation profiles of your samples to guarantee the compliance of your products.
Our analysis services
Identification and fine characterization of glycosylated structures
Complementary structural characterization
Characterization of therapeutic glycoproteins, biosimilars and vaccines.
Separation and analysis of derivatized glycans
